Sunshine Bancorp, Inc
SBCP
SBCP was delisted on the 29th of December, 2017.
12 hedge funds and large institutions have $10M invested in Sunshine Bancorp, Inc in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
15% more capital invested
Capital invested by funds: $8.68M → $10M (+$1.34M)
8% less funds holding
Funds holding: 13 → 12 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SJ
Stilwell Joseph
|
+$510K |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$364K |
| 3 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$96.4K |
| 4 |
MCM
Maltese Capital Management
New York
|
+$83.2K |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$988 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$747 |
SBCP Hedge Fund Activity: Q4 2014 in Review
12 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Sunshine Bancorp, Inc (SBCP) for Q4 2014, worth a combined $10M — up 15% from $8.68M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SBCP positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Stilwell Joseph, opening a new position worth an estimated $510K. The largest seller was Tower Research Capital (TRC), cutting an estimated $747.
- 12 institutional investors held Sunshine Bancorp, Inc (SBCP) as of Q4 2014, down from 13 in Q3 2014.
- Funds reported $10M of Sunshine Bancorp, Inc stock for Q4 2014, up 15% quarter-over-quarter.
- 1 fund opened new Sunshine Bancorp, Inc positions in Q4 2014 and 0 closed out, a net change of +1 holder.
- The largest Sunshine Bancorp, Inc buyer in Q4 2014 was Stilwell Joseph, an estimated $510K added.
- The largest Sunshine Bancorp, Inc seller in Q4 2014 was Tower Research Capital (TRC), an estimated $747 sold.
Based on aggregated 13F filings for Q4 2014.